|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61P 21/00 | (2006.01) | ||
| C07K 14/47 | (2006.01) | ||
| C12N 15/12 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 3442600 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17783207.8 |
| Date of filing the European patent application | 2017-04-14 | |
| (97) | Date of publication of the European application | 2019-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation | 2024-05-27 |
| (86) | Number | PCT/US2017/027583 |
| Date | 2017-04-14 |
| (87) | Number | WO 2017/180976 |
| Date | 2017-10-19 |
| (30) | Number | Date | Country code |
| 201662323333 P | 2016-04-15 | US | |
| 201662433548 P | 2016-12-13 | US |
| (72) |
RODINO-KLAPAC, Louise , US
MENDELL, Jerry, R. , US
|
| (73) |
Research Institute at Nationwide
Children's Hospital ,
700 Children's Drive, Room W172,, Columbus, Ohio 43205,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Su adeno virusu susijusio viruso vektoriaus iš β-sarkoglikano ir mikro- RNR-29 pristatymas ir raumenų distrofijos gydymas |
| ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY |
| Payment date | Validity (years) | Amount | |
| 2025-03-05 | 9 | 208.00 EUR |
| 2026-04-14 |